Results of the RESORT Trial for Follicular Lymphoma from ASH 2011
Description: For patients with low-tumor-burden follicular lymphoma, initial treatment options are varied. Presented at the 2011 ASH meeting, the RESORT trial examined treatment with single-agent rituximab, seeking to discover whether patients do better with maintenance therapy or retreatment on an as-needed basis. Though the trial concluded that both strategies can be successful, RESORT co-author Dr. Brad Kahl, from the University of Wisconsin Carbone Cancer Center, gives an in-depth explanation of the many factors that come into play and stresses that treatment decisions require an engaged dialog between lymphoma patients and their physicians.
Shared By : patientpower
Posted on : 03/20/12
Added : 5 years ago